Company performance
Add to research
Current Price
as of Jun 20, 2025$2.82
P/E Ratio
N/A
Market Cap
$24.96M
Description
Add to research
Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley on November 28, 2005 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerDARE
- Price$2.82-3.42%
Trading Information
- Market cap$24.96M
- Float98.41%
- Average Daily Volume (1m)35,034
- Average Daily Volume (3m)21,009
- EPS-$0.48
Company
- Revenue$0.01M
- Rev growth (1yr)173.35%
- Net income-$4.38M
- Gross margin-1,009.12%
- EBITDA margin-16,907.62%
- EBITDA-$4.30M
- EV$23.39M
- EV/Revenue2,390.59
- P/EN/A
- P/S2,524.58
- P/BN/A
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset